Century Therapeutics Stock Forward View - Relative Strength Index
| IPSC Stock | USD 2.01 0.35 14.83% |
Century Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Century Therapeutics stock prices and determine the direction of Century Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Century Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
The value of RSI of Century Therapeutics' stock price is about 60. This usually indicates that the stock is rather overbought by investors at the present time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Century, making its price go up or down. Momentum 60
Buy Extended
Oversold | Overbought |
Using Century Therapeutics hype-based prediction, you can estimate the value of Century Therapeutics from the perspective of Century Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Century Therapeutics after-hype prediction price | USD 2.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Century Therapeutics to cross-verify your projections. For information on how to trade Century Stock refer to our How to Trade Century Stock guide.Century Therapeutics Additional Predictive Modules
Most predictive techniques to examine Century price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Century using various technical indicators. When you analyze Century charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 60.24 | 60.24 |
| Check Century Therapeutics Volatility | Backtest Century Therapeutics | Information Ratio |
Century Therapeutics Trading Date Momentum
| On January 29 2026 Century Therapeutics was traded for 2.01 at the closing time. The top price for the day was 2.37 and the lowest listed price was 1.99 . The trading volume for the day was 1.5 M. The trading history from January 29, 2026 did not affect price variability. The overall trading delta against the current closing price is 17.91% . |
| Compare Century Therapeutics to competition |
Other Forecasting Options for Century Therapeutics
For every potential investor in Century, whether a beginner or expert, Century Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Century Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Century. Basic forecasting techniques help filter out the noise by identifying Century Therapeutics' price trends.Century Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Century Therapeutics stock to make a market-neutral strategy. Peer analysis of Century Therapeutics could also be used in its relative valuation, which is a method of valuing Century Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Century Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Century Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Century Therapeutics shares will generate the highest return on investment. By undertsting and applying Century Therapeutics stock market strength indicators, traders can identify Century Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 240532.0 | |||
| Daily Balance Of Power | (0.92) | |||
| Rate Of Daily Change | 0.85 | |||
| Day Median Price | 2.18 | |||
| Day Typical Price | 2.12 | |||
| Price Action Indicator | (0.35) | |||
| Period Momentum Indicator | (0.35) | |||
| Relative Strength Index | 60.24 |
Century Therapeutics Risk Indicators
The analysis of Century Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Century Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting century stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.36 | |||
| Semi Deviation | 5.6 | |||
| Standard Deviation | 9.85 | |||
| Variance | 97.04 | |||
| Downside Variance | 64.21 | |||
| Semi Variance | 31.34 | |||
| Expected Short fall | (8.24) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Century Therapeutics
The number of cover stories for Century Therapeutics depends on current market conditions and Century Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Century Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Century Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Century Therapeutics Short Properties
Century Therapeutics' future price predictability will typically decrease when Century Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Century Therapeutics often depends not only on the future outlook of the potential Century Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Century Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 78.6 M | |
| Cash And Short Term Investments | 189.3 M |
Check out Historical Fundamental Analysis of Century Therapeutics to cross-verify your projections. For information on how to trade Century Stock refer to our How to Trade Century Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Will Stock sector continue expanding? Could Century diversify its offerings? Factors like these will boost the valuation of Century Therapeutics. Market participants price Century higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Century Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Century Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Century Therapeutics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Century Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Century Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Century Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Century Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.